These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 7646824

  • 21. [Ocular disorders during treatment with neuroleptics and thymoleptics].
    Cuendet JF, Verrey F, Nouri A, Rosselet E, Faggioni R.
    Bull Soc Belge Ophtalmol; 1972; 160(2):601-6. PubMed ID: 4656814
    [No Abstract] [Full Text] [Related]

  • 22. Hypercholesterolemia-induced ocular disorder: Ameliorating role of phytotherapy.
    El-Sayyad HI, Elmansi AA, Bakr EH.
    Nutrition; 2015; 31(11-12):1307-16. PubMed ID: 26429651
    [Abstract] [Full Text] [Related]

  • 23. Chloroquine ocular toxicity.
    Bernstein HN.
    Surv Ophthalmol; 1967 Oct; 12(5):415-47. PubMed ID: 4980087
    [No Abstract] [Full Text] [Related]

  • 24. Incidence and significance of chlorpromazine-induced eye changes.
    De Long SL.
    Dis Nerv Syst; 1968 Mar; 29(3):Suppl:19-22. PubMed ID: 4876741
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Ultrasonographic comparative study of the effect of pilocarpine and aceclidine on the eye components.
    François J, Goes F.
    Bibl Ophthalmol; 1975 Mar; (83):320-7. PubMed ID: 1131237
    [No Abstract] [Full Text] [Related]

  • 28. [Iatrogenic pathology of the eye].
    Watillon M.
    Rev Med Liege; 1986 May 01; 41(9):361-76. PubMed ID: 3523671
    [No Abstract] [Full Text] [Related]

  • 29. Ultrasonographic comparative study of the effect of pilocarpine and aceclidine on the eye components.
    François J, Goes F.
    Ophthalmologica; 1974 May 01; 168(4):299-307. PubMed ID: 4837179
    [No Abstract] [Full Text] [Related]

  • 30. Ocular complications of oral contraceptives.
    Wood JR.
    Ophthalmic Semin; 1977 May 01; 2(4):371-402. PubMed ID: 306593
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Ocular complications of chlorpromazine therapy.
    Petrohelos MA, Tricoulis D.
    Ophthalmologica; 1969 May 01; 158 Suppl():469-76. PubMed ID: 4982681
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prognosis of eye complications caused by phenothiazines.
    Forrest FM, Snow HL.
    Dis Nerv Syst; 1968 Mar 01; 29(3):Suppl:26-8. PubMed ID: 5672560
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Detection of glutamate in the eye by Raman spectroscopy.
    Katz A, Kruger EF, Minko G, Liu CH, Rosen RB, Alfano RR.
    J Biomed Opt; 2003 Apr 01; 8(2):167-72. PubMed ID: 12683841
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. [Ophthalmologic effects of corticotherapy in kidney diseases treated by dialysis and kidney transplantation].
    Rousselie F, Fontaine M, Wassermann-Thomine A.
    Bull Mem Soc Fr Ophtalmol; 1976 Apr 01; (87):58-62. PubMed ID: 773462
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.